Oral HIV pre-exposure prophylaxis use and resistanceassociated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022.

MLA

Jongen, Vita W., et al. “Oral HIV Pre-Exposure Prophylaxis Use and Resistanceassociated Mutations among Men Who Have Sex with Men and Transgender Persons Newly Diagnosed with HIV in the Netherlands: Results from the ATHENA Cohort, 2018 to 2022.” Eurosurveillance (15607917), vol. 29, no. 38, Sept. 2024, pp. 33–43. EBSCOhost, https://doi.org/10.2807/1560-7917.ES.2024.29.38.2400083.

APA

Jongen, V. W., Bezemer, D., van Sighem, A., Boyd, A., Rokx, C., Grintjes, K., Cents-Bosma, A., de Coul, E. O., van Benthem, B., Wensing, A., Wit, F. W. N. M., & van der Valk, M. (2024). Oral HIV pre-exposure prophylaxis use and resistanceassociated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022. Eurosurveillance (15607917), 29(38), 33–43. https://doi.org/10.2807/1560-7917.ES.2024.29.38.2400083

Chicago

Jongen, Vita W., Daniela Bezemer, Ard van Sighem, Anders Boyd, Casper Rokx, Karin Grintjes, Aafke Cents-Bosma, et al. 2024. “Oral HIV Pre-Exposure Prophylaxis Use and Resistanceassociated Mutations among Men Who Have Sex with Men and Transgender Persons Newly Diagnosed with HIV in the Netherlands: Results from the ATHENA Cohort, 2018 to 2022.” Eurosurveillance (15607917) 29 (38): 33–43. doi:10.2807/1560-7917.ES.2024.29.38.2400083.